Inflammatory Disease Marker Tests – Medical Devices Pipeline Assessment, 2020

Inflammatory Disease Markers are antigen/antibodies that detect specific antigen/antibodies produced by bone, cartilage or any other inflammatory disease activity. This segment includes sub segment analyzer based tests and latex agglutination based tests. GlobalData's Medical Devices sector report, “Inflammatory Disease Marker Tests – Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inflammatory Disease Marker Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Inflammatory Disease Marker Tests Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Inflammatory Disease Marker Tests under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Inflammatory Disease Marker Tests pipeline products.

Review of Recent Developments in the segment / industry

The Inflammatory Disease Marker Tests Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Inflammatory Disease Marker Tests- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Inflammatory Disease Marker Tests under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Inflammatory Disease Marker Tests and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Inflammatory Disease Marker Tests under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Abcodia Ltd

Adaltis Srl

Albert Ludwigs University of Freiburg

AnaMar AB

Arizona State University

AXO Science SAS

Beckman Coulter Inc

BIOHOPE Scientific SL

BiomX Inc

BioSIMS

Boditech Med Inc

CD Diagnostics Inc

CDI Laboratories Inc

Chronix Biomedical Inc

Cincinnati Children's Hospital Medical Center

Consejo Superior de Investigaciones Cientificas

Crescendo Bioscience Inc

DSX Therapeutics LLC

DxTerity Diagnostics Inc

EKF Diagnostics Holdings Plc

ELITechGroup Inc

Firalis SAS

French National Institute of Health and Medical Research

Genalyte Inc

Ghent University

Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)

Ignyta Inc

Johns Hopkins University

KineMed Inc

Leadgene Biomedical Inc

LifeAssays AB

Medica Corp

Merck Millipore Corp

Morehouse School of Medicine

Myriad Genetics Inc

Neoteryx LLC

Ortho-Clinical Diagnostics Inc

Phagolum Ltd.

Proplex Technologies Llc

Protagen AG

Queen Mary University of London

Quidel Corp

Roche Diagnostics Corp

Selventa Inc

Siemens Healthcare Diagnostics Inc

SomaLogic Inc

SpinChip Diagnostics AS

SQI Diagnostics Inc

StageZero Life Sciences Ltd

Svar Life Science AB

The University of Manchester

The Walter and Eliza Hall Institute of Medical Research

Thermo Fisher Scientific Inc

Toscana Biomarkers Srl

University Health Network

University of Aberdeen

University of Auckland

University of California

University of California Los Angeles

University of Gottingen

University of Oxford

University of Rochester

University of Warwick

University Rovira i Virgili

Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 10

2 Introduction 11

2.1 Inflammatory Disease Markers Overview 11

3 Products under Development 12

3.1 Inflammatory Disease Markers – Pipeline Products by Stage of Development 12

3.2 Inflammatory Disease Markers – Pipeline Products by Segment 13

3.3 Inflammatory Disease Markers – Pipeline Products by Territory 14

3.4 Inflammatory Disease Markers – Pipeline Products by Regulatory Path 15

3.5 Inflammatory Disease Markers – Pipeline Products by Estimated Approval Date 16

4 Inflammatory Disease Markers – Pipeline Products under Development by Companies 17

4.1 Inflammatory Disease Markers Companies – Pipeline Products by Stage of Development 17

4.2 Inflammatory Disease Markers – Pipeline Products by Stage of Development 20

5 Inflammatory Disease Markers Companies and Product Overview 23

5.1 Abcodia Ltd Company Overview 23

5.1.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Adaltis Srl Company Overview 24

5.2.1 Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Albert Ludwigs University of Freiburg Company Overview 25

5.3.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 AnaMar AB Company Overview 26

5.4.1 AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Arizona State University Company Overview 27

5.5.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 AXO Science SAS Company Overview 28

5.6.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Beckman Coulter Inc Company Overview 29

5.7.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 BIOHOPE Scientific SL Company Overview 39

5.8.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 39

5.9 BiomX Inc Company Overview 40

5.9.1 BiomX Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.10 BioSIMS Company Overview 41

5.10.1 BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 41

5.11 Boditech Med Inc Company Overview 42

5.11.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.12 CD Diagnostics Inc Company Overview 45

5.12.1 CD Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.13 CDI Laboratories Inc Company Overview 46

5.13.1 CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.14 Chronix Biomedical Inc Company Overview 47

5.14.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.15 Cincinnati Children's Hospital Medical Center Company Overview 48

5.15.1 Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 48

5.16 Consejo Superior de Investigaciones Cientificas Company Overview 49

5.16.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 49

5.17 Crescendo Bioscience Inc Company Overview 50

5.17.1 Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.18 DSX Therapeutics LLC Company Overview 51

5.18.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.19 DxTerity Diagnostics Inc Company Overview 52

5.19.1 DxTerity Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.20 EKF Diagnostics Holdings Plc Company Overview 53

5.20.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 53

5.21 ELITechGroup Inc Company Overview 54

5.21.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.22 Firalis SAS Company Overview 57

5.22.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 57

5.23 French National Institute of Health and Medical Research Company Overview 58

5.23.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 58

5.24 Genalyte Inc Company Overview 59

5.24.1 Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.25 Ghent University Company Overview 60

5.25.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 60

5.26 Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Company Overview 61

5.26.1 Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Pipeline Products & Ongoing Clinical Trials Overview 61

5.27 Ignyta Inc Company Overview 63

5.27.1 Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.28 Johns Hopkins University Company Overview 64

5.28.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 64

5.29 KineMed Inc Company Overview 66

5.29.1 KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.30 Leadgene Biomedical Inc Company Overview 67

5.30.1 Leadgene Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.31 LifeAssays AB Company Overview 68

5.31.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 68

5.32 Medica Corp Company Overview 69

5.32.1 Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 69

5.33 Merck Millipore Corp Company Overview 70

5.33.1 Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 70

5.34 Morehouse School of Medicine Company Overview 71

5.34.1 Morehouse School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 71

5.35 Myriad Genetics Inc Company Overview 72

5.35.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.36 Neoteryx LLC Company Overview 73

5.36.1 Neoteryx LLC Pipeline Products & Ongoing Clinical Trials Overview 73

5.37 Ortho-Clinical Diagnostics Inc Company Overview 74

5.37.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.38 Phagolum Ltd. Company Overview 76

5.38.1 Phagolum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76

5.39 Proplex Technologies Llc Company Overview 77

5.39.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 77

5.40 Protagen AG Company Overview 78

5.40.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 78

5.41 Queen Mary University of London Company Overview 79

5.41.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 79

5.42 Quidel Corp Company Overview 80

5.42.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 80

5.43 Roche Diagnostics Corp Company Overview 81

5.43.1 Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 81

5.44 Selventa Inc Company Overview 83

5.44.1 Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.45 Siemens Healthcare Diagnostics Inc Company Overview 84

5.45.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.46 SomaLogic Inc Company Overview 87

5.46.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.47 SpinChip Diagnostics AS Company Overview 88

5.47.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 88

5.48 SQI Diagnostics Inc Company Overview 89

5.48.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.49 StageZero Life Sciences Ltd Company Overview 90

5.49.1 StageZero Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.50 Svar Life Science AB Company Overview 91

5.50.1 Svar Life Science AB Pipeline Products & Ongoing Clinical Trials Overview 91

5.51 The University of Manchester Company Overview 93

5.51.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 93

5.52 The Walter and Eliza Hall Institute of Medical Research Company Overview 94

5.52.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 94

5.53 Thermo Fisher Scientific Inc Company Overview 95

5.53.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.54 Toscana Biomarkers Srl Company Overview 96

5.54.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 96

5.55 University Health Network Company Overview 97

5.55.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview 97

5.56 University of Aberdeen Company Overview 98

5.56.1 University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview 98

5.57 University of Auckland Company Overview 99

5.57.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 99

5.58 University of California Company Overview 100

5.58.1 University of California Pipeline Products & Ongoing Clinical Trials Overview 100

5.59 University of California Los Angeles Company Overview 101

5.59.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 101

5.60 University of Gottingen Company Overview 102

5.60.1 University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview 102

5.61 University of Oxford Company Overview 103

5.61.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 103

5.62 University of Rochester Company Overview 104

5.62.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 104

5.63 University of Warwick Company Overview 105

5.63.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 105

5.64 University Rovira i Virgili Company Overview 106

5.64.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 106

6 Inflammatory Disease Markers- Recent Developments 107

6.1 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia 107

6.2 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities 107

6.3 May 04, 2020: StageZero Life Sciences announces enhanced relationship with Phleb-Finders 108

6.4 Mar 03, 2020: Epigenetic DNA modifications can predict asthma and rhinitis 108

6.5 Feb 27, 2020: SQI Diagnostics reports first quarter 2020 results 109

6.6 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors 112

6.7 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results 112

6.8 Feb 06, 2020: Myriad announces leadership transition 114

6.9 Feb 06, 2020: Myriad Genetics reports fiscal second-quarter 2020 financial results 115

6.10 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users 117

6.11 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed 117

6.12 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results 120

6.13 Jan 30, 2020: Theradiag reports 2019 revenue of €9.6 million, Up

8.3% 122

6.14 Jan 14, 2020: Dr. Thomas P. Slavin named Senior Vice President of Medical Affairs for Myriad Oncology 124

6.15 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President 124

6.16 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control 125

6.17 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents 125

6.18 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack 126

6.19 Dec 11, 2019: SQI Diagnostics Reports Fourth Quarter and Fiscal 2019 Results and Management Changes 126

6.20 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses 129

6.21 Nov 27, 2019: Construction completed on Otsuka's new pharmaceutical factory plant in Mima City, Tokushima Prefecture, Japan 130

7 Appendix 131

7.1 Methodology 131

7.2 About GlobalData 135

7.3 Contact Us 135

List of Tables

Table 1: Inflammatory Disease Markers – Pipeline Products by Stage of Development 12

Table 2: Inflammatory Disease Markers – Pipeline Products by Segment 13

Table 3: Inflammatory Disease Markers – Pipeline Products by Territory 14

Table 4: Inflammatory Disease Markers – Pipeline Products by Regulatory Path 15

Table 5: Inflammatory Disease Markers – Pipeline Products by Estimated Approval Date 16

Table 6: Inflammatory Disease Markers Companies – Pipeline Products by Stage of Development 17

Table 7: Inflammatory Disease Markers – Pipeline Products by Stage of Development 20

Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Table 9: Molecular Biomarker – Rheumatoid Arthritis – Product Status 23

Table 10: Molecular Biomarker – Rheumatoid Arthritis – Product Description 23

Table 11: Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 24

Table 12: Hemo One – hs – CRP Assay – Product Status 24

Table 13: Hemo One – hs – CRP Assay – Product Description 24

Table 14: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 25

Table 15: Diagnostic Kit – Rheumatoid Arthritis – Product Status 25

Table 16: Diagnostic Kit – Rheumatoid Arthritis – Product Description 25

Table 17: AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview 26

Table 18: NeoSix Biomarker Assay – Product Status 26

Table 19: NeoSix Biomarker Assay – Product Description 26

Table 20: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 27

Table 21: Diagnostic Test – Rheumatoid Arthritis – Product Status 27

Table 22: Diagnostic Test – Rheumatoid Arthritis – Product Description 27

Table 23: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 28

Table 24: Multiplexed Detection – CRP – Product Status 28

Table 25: Multiplexed Detection – CRP – Product Description 28

Table 26: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 27: AU480 Clinical System – anti-CCP Assay – Product Status 29

Table 28: AU480 Clinical System – anti-CCP Assay – Product Description 30

Table 29: AU5810 Clinical System – anti-CCP Assay – Product Status 30

Table 30: AU5810 Clinical System – anti-CCP Assay – Product Description 30

Table 31: AU5820 Clinical System – anti-CCP Assay – Product Status 31

Table 32: AU5820 Clinical System – anti-CCP Assay – Product Description 31

Table 33: AU5830 Clinical System – anti-CCP Assay – Product Status 31

Table 34: AU5830 Clinical System – anti-CCP Assay – Product Description 32

Table 35: AU5840 Clinical System – anti-CCP Assay – Product Status 32

Table 36: AU5840 Clinical System – anti-CCP Assay – Product Description 32

Table 37: AU680 Clinical System – anti-CCP Assay – Product Status 33

Table 38: AU680 Clinical System – anti-CCP Assay – Product Description 33

Table 39: Multisystem Inflammatory Syndrome Diagnostic Test – Product Status 33

Table 40: Multisystem Inflammatory Syndrome Diagnostic Test – Product Description 34

Table 41: UniCel DxC 600 – anti-CCP Assay – Product Status 34

Table 42: UniCel DxC 600 – anti-CCP Assay – Product Description 34

Table 43: UniCel DxC 600i Synchron Access – anti-CCP Assay – Product Status 35

Table 44: UniCel DxC 600i Synchron Access – anti-CCP Assay – Product Description 35

Table 45: UniCel DxC 680i Synchron Access Clinical System – anti-CCP Assay – Product Status 35

Table 46: UniCel DxC 680i Synchron Access Clinical System – anti-CCP Assay – Product Description 36

Table 47: UniCel DxC 800 – anti-CCP Assay – Product Status 36

Table 48: UniCel DxC 800 – anti-CCP Assay – Product Description 36

Table 49: UniCel DxC 860i Synchron Access Clinical System – anti-CCP Assay – Product Status 37

Table 50: UniCel DxC 860i Synchron Access Clinical System – anti-CCP Assay – Product Description 37

Table 51: UniCel DxC 880i Synchron Access Clinical System – anti-CCP Assay – Product Status 37

Table 52: UniCel DxC 880i Synchron Access Clinical System – anti-CCP Assay – Product Description 38

Table 53: BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 39

Table 54: Inmunobiogram – Arthritis – Product Status 39

Table 55: Inmunobiogram – Arthritis – Product Description 39

Table 56: BiomX Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Table 57: Diagnostic Test – IBD – Product Status 40

Table 58: Diagnostic Test – IBD – Product Description 40

Table 59: BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 41

Table 60: DigiPLEX Analyzer – Rheumatology Assay – Product Status 41

Table 61: DigiPLEX Analyzer – Rheumatology Assay – Product Description 41

Table 62: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Table 63: AFIAS 1 – Anti-CCP Plus Assay – Product Status 42

Table 64: AFIAS 1 – Anti-CCP Plus Assay – Product Description 43

Table 65: AFIAS 6 – Anti-CCP Plus Assay – Product Status 43

Table 66: AFIAS 6 – Anti-CCP Plus Assay – Product Description 43

Table 67: AFIAS-6 RF IgM Assay – Product Status 44

Table 68: AFIAS-6 RF IgM Assay – Product Description 44

Table 69: CD Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 70: Cygnasure Diagnostic Immunoassay – Rheumatoid Arthritis – Product Status 45

Table 71: Cygnasure Diagnostic Immunoassay – Rheumatoid Arthritis – Product Description 45

Table 72: CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Table 73: Diagnostic Test – Rheumatoid Arthritis – Product Status 46

Table 74: Diagnostic Test – Rheumatoid Arthritis – Product Description 46

Table 75: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Table 76: Companion Diagnostic Test – Rheumatoid Arthritis – Product Status 47

Table 77: Companion Diagnostic Test – Rheumatoid Arthritis – Product Description 47

Table 78: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 48

Table 79: Diagnostic And Prognostic Assay – Crohn’s Disease – Product Status 48

Table 80: Diagnostic And Prognostic Assay – Crohn’s Disease – Product Description 48

Table 81: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 49

Table 82: Diagnostic Assay – Rheumatoid Arthritis – Product Status 49

Table 83: Diagnostic Assay – Rheumatoid Arthritis – Product Description 49

Table 84: Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Table 85: Multi-Biomarker Test – Inflammatory Diseases – Product Status 50

Table 86: Multi-Biomarker Test – Inflammatory Diseases – Product Description 50

Table 87: DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 51

Table 88: Diagnostic Test – Rheumatoid Arthritis – Product Status 51

Table 89: Diagnostic Test – Rheumatoid Arthritis – Product Description 51

Table 90: DxTerity Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Table 91: Dxterity Kit – RA – Product Status 52

Table 92: Dxterity Kit – RA – Product Description 52

Table 93: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 53

Table 94: Quo-Lab – C-Reactive Protein – Product Status 53

Table 95: Quo-Lab – C-Reactive Protein – Product Description 53

Table 96: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Table 97: Eon 100 Automated Chemistry Analyzer – CRP Wide Range Assay – Product Status 54

Table 98: Eon 100 Automated Chemistry Analyzer – CRP Wide Range Assay – Product Description 54

Table 99: Eon 300 Automated Chemistry Analyzer – CRP Wide Range Assay – Product Status 55

Table 100: Eon 300 Automated Chemistry Analyzer – CRP Wide Range Assay – Product Description 55

Table 101: Selectra ProS Chemistry System – CRP Wide Range Assay – Product Status 55

Table 102: Selectra ProS Chemistry System – CRP Wide Range Assay – Product Description 56

Table 103: Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 57

Table 104: Biomarker Test – Rheumatoid Arthritis – Product Status 57

Table 105: Biomarker Test – Rheumatoid Arthritis – Product Description 57

Table 106: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 58

Table 107: GPI Biomarker Assay – Arthritis – Product Status 58

Table 108: GPI Biomarker Assay – Arthritis – Product Description 58

Table 109: Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Table 110: Maverick Rheumatoid Arthritis Multiplex Assay Kit – Product Status 59

Table 111: Maverick Rheumatoid Arthritis Multiplex Assay Kit – Product Description 59

Table 112: Ghent University Pipeline Products & Ongoing Clinical Trials Overview 60

Table 113: Biomarker Test – Spondyloarthropathy – Product Status 60

Table 114: Biomarker Test – Spondyloarthropathy – Product Description 60

Table 115: Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Pipeline Products & Ongoing Clinical Trials Overview 61

Table 116: Biomarker Assay – Inflammatory Disease – Product Status 61

Table 117: Biomarker Assay – Inflammatory Disease – Product Description 62

Table 118: Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 119: CLIA Waived Diagnostic Test – Rheumatoid Arthritis – Product Status 63

Table 120: CLIA Waived Diagnostic Test – Rheumatoid Arthritis – Product Description 63

Table 121: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 64

Table 122: Anti-PAD3 Based Diagnostic Assay – Rheumatoid Arthritis – Product Status 64

Table 123: Anti-PAD3 Based Diagnostic Assay – Rheumatoid Arthritis – Product Description 64

Table 124: Biomarker Assay – Rheumatoid Arthritis – Product Status 65

Table 125: Biomarker Assay – Rheumatoid Arthritis – Product Description 65

Table 126: KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Table 127: Diagnostic Assay – Collagen Synthesis – Product Status 66

Table 128: Diagnostic Assay – Collagen Synthesis – Product Description 66

Table 129: Leadgene Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Table 130: IL-8 Diagnostic Kit – Product Status 67

Table 131: IL-8 Diagnostic Kit – Product Description 67

Table 132: LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 68

Table 133: LifeAssays hsCRP – Product Status 68

Table 134: LifeAssays hsCRP – Product Description 68

Table 135: Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 69

Table 136: EasyRA Analyzer – RF Assay – Product Status 69

Table 137: EasyRA Analyzer – RF Assay – Product Description 69

Table 138: Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 70

Table 139: Erenna System – Rheumatoid Arthritis – Product Status 70

Table 140: Erenna System – Rheumatoid Arthritis – Product Description 70

Table 141: Morehouse School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 71

Table 142: Diagnostic Assay – Shift Work Exposure – Product Status 71

Table 143: Diagnostic Assay – Shift Work Exposure – Product Description 71

Table 144: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 72

Table 145: myPath Psoriatic Arthritis – Product Status 72

Table 146: myPath Psoriatic Arthritis – Product Description 72

Table 147: Neoteryx LLC Pipeline Products & Ongoing Clinical Trials Overview 73

Table 148: VAMS Device – Inflammatory Bowel Disease Assay – Product Status 73

Table 149: VAMS Device – Inflammatory Bowel Disease Assay – Product Description 73

Table 150: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 74

Table 151: VITROS 4600 – CRP Ultra (MP) Assay – Product Status 74

Table 152: VITROS 4600 – CRP Ultra (MP) Assay – Product Description 74

Table 153: VITROS 5600 – CRP Ultra (MP) Assay – Product Status 75

Table 154: VITROS 5600 – CRP Ultra (MP) Assay – Product Description 75

Table 155: Phagolum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76

Table 156: Diagnostic Test – Inflammatory Diseases – Product Status 76

Table 157: Diagnostic Test – Inflammatory Diseases – Product Description 76

Table 158: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 77

Table 159: Biomarker Diagnostic Test – Rheumatoid Arthritis – Product Status 77

Table 160: Biomarker Diagnostic Test – Rheumatoid Arthritis – Product Description 77

Table 161: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 78

Table 162: NavigAID – Rheumatoid Arthritis – Product Status 78

Table 163: NavigAID – Rheumatoid Arthritis – Product Description 78

Table 164: Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 79

Table 165: Biomarker Assay – Rheumatoid Arthritis – Product Status 79

Table 166: Biomarker Assay – Rheumatoid Arthritis – Product Description 79

Table 167: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 80

Table 168: Next Generation IA System – Inflammation Assay – Product Status 80

Table 169: Next Generation IA System – Inflammation Assay – Product Description 80

Table 170: Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 81

Table 171: TrailblazeDx Test – Rheumatoid Arthritis – Product Status 81

Table 172: TrailblazeDx Test – Rheumatoid Arthritis – Product Description 81

Table 173: TrailblazeTx Test – Rheumatoid Arthritis – Product Status 82

Table 174: TrailblazeTx Test – Rheumatoid Arthritis – Product Description 82

Table 175: Selventa Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Table 176: Clarify – Rheumatoid Arthritis – Product Status 83

Table 177: Clarify – Rheumatoid Arthritis – Product Description 83

Table 178: Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 84

Table 179: ADVIA Centaur XPT Immunoassay System – LBP Assay – Product Status 84

Table 180: ADVIA Centaur XPT Immunoassay System – LBP Assay – Product Description 84

Table 181: Atellica IM Analyzer – IL-6 Assay – Product Status 85

Table 182: Atellica IM Analyzer – IL-6 Assay – Product Description 85

Table 183: Atellica IM Analyzer – LBP Assay – Product Status 85

Table 184: Atellica IM Analyzer – LBP Assay – Product Description 86

Table 185: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 87

Table 186: SomaSignal Test – Rheumatoid Arthritis – Product Status 87

Table 187: SomaSignal Test – Rheumatoid Arthritis – Product Description 87

Table 188: SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 88

Table 189: Spinchip – Interleukin 6 Assay – Product Status 88

Table 190: Spinchip – Interleukin 6 Assay – Product Description 88

Table 191: SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Table 192: Ig_PLEX Rheumatoid Arthritis Panel With Expanded Markers – Product Status 89

Table 193: Ig_PLEX Rheumatoid Arthritis Panel With Expanded Markers – Product Description 89

Table 194: StageZero Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

Table 195: Biomarker Diagnostic Test – Rheumatoid Arthritis – Product Status 90

Table 196: Biomarker Diagnostic Test – Rheumatoid Arthritis – Product Description 90

Table 197: Svar Life Science AB Pipeline Products & Ongoing Clinical Trials Overview 91

Table 198: Diagnostic Test – IBD – Product Status 91

Table 199: Diagnostic Test – IBD – Product Description 91

Table 200: Diagnostic Test – Rheumatoid Arthritis – Product Status 92

Table 201: Diagnostic Test – Rheumatoid Arthritis – Product Description 92

Table 202: The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 93

Table 203: Molecular Pathology Test – Rheumatoid Arthritis – Product Status 93

Table 204: Molecular Pathology Test – Rheumatoid Arthritis – Product Description 93

Table 205: The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 94

Table 206: Diagnostic Test – Acute Rheumatic Fever – Product Status 94

Table 207: Diagnostic Test – Acute Rheumatic Fever – Product Description 94

Table 208: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 95

Table 209: Phadia 5000 Laboratory System – CCP Test – Product Status 95

Table 210: Phadia 5000 Laboratory System – CCP Test – Product Description 95

Table 211: Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 96

Table 212: Diagnostic Assay – Rheumatoid Arthritis – Product Status 96

Table 213: Diagnostic Assay – Rheumatoid Arthritis – Product Description 96

Table 214: University Health Network Pipeline Products & Ongoing Clinical Trials Overview 97

Table 215: Biomarker Test – Rheumatoid Arthritis – Product Status 97

Table 216: Biomarker Test – Rheumatoid Arthritis – Product Description 97

Table 217: University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview 98

Table 218: Diagnostic Assay – Rheumatoid Arthritis – Product Status 98

Table 219: Diagnostic Assay – Rheumatoid Arthritis – Product Description 98

Table 220: University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 99

Table 221: Diagnostic Test – Rheumatic Fever – Product Status 99

Table 222: Diagnostic Test – Rheumatic Fever – Product Description 99

Table 223: University of California Pipeline Products & Ongoing Clinical Trials Overview 100

Table 224: Biomarker Test – Inflammatory Bowel Disease – Product Status 100

Table 225: Biomarker Test – Inflammatory Bowel Disease – Product Description 100

Table 226: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 101

Table 227: Diagnostic Biomarker Test – Inflammatory Bowel Disease – Product Status 101

Table 228: Diagnostic Biomarker Test – Inflammatory Bowel Disease – Product Description 101

Table 229: University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview 102

Table 230: C3aR-Based Diagnostic Assay – Product Status 102

Table 231: C3aR-Based Diagnostic Assay – Product Description 102

Table 232: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 103

Table 233: Biomarker Based Assay – Rheumatoid Arthritis – Product Status 103

Table 234: Biomarker Based Assay – Rheumatoid Arthritis – Product Description 103

Table 235: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 104

Table 236: PBMC-Based Companion Diagnostic Test – Product Status 104

Table 237: PBMC-Based Companion Diagnostic Test – Product Description 104

Table 238: University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 105

Table 239: Diagnostic Test – Arthritis – Product Status 105

Table 240: Diagnostic Test – Arthritis – Product Description 105

Table 241: University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 106

Table 242: CD-Medics Test – RA – Product Status 106

Table 243: CD-Medics Test – RA – Product Description 106

List of Figures

Figure 1: Inflammatory Disease Markers – Pipeline Products by Stage of Development 12

Figure 2: Inflammatory Disease Markers – Pipeline Products by Segment 13

Figure 3: Inflammatory Disease Markers – Pipeline Products by Territory 14

Figure 4: Inflammatory Disease Markers – Pipeline Products by Regulatory Path 15

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports